for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Aurinia Pharmaceuticals Reports Qtrly Loss Per Share ‍of $0.04​

March 15 (Reuters) - Aurinia Pharmaceuticals Inc:

* AURINIA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

* AURINIA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.04

* AURINIA PHARMACEUTICALS INC - TRIALS IN FSGS AND DRY EYE TO BEGIN IN Q2 2018 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up